L51 - ANNESHA

Name : Mr. ISHANK GUPTA Collected :15/4/2022 5:00:00PM

Received :15/4/2022 6:19:16PM
Lab No. : 309575476 Age: 20 Years Gender: Male
Reported :16/4/2022
10:33:29AM
A/c Status : P Ref By : Dr. .SELF Report Status : Final

SRF ID : 1931200231237

Test Name Results

SARS-CoV-2 (COVID-19) QUALITATIVE REAL TIME RT-PCR * (Real Time PCR)

Type of Specimen Nasopharyngeal /

Oropharyngeal Swabs Result Negative

Condition of specimen received / Quality on arrival: Good Quality Specimen / In Cold Chain

Note
1. ICMR Registration number for Covid -19 is DLPLL001. Please scan the QR code given at end of this
report to check the authenticity of the report.
2. Negative result does not rule out the possibility of Covid-19 infection. Presence of inhibitors, mutations &
insufficient RNA specific to SARS-CoV-2 can influence the test result. Kindly correlate the results with
clinical findings. A negative result in a single upper respiratory tract sample does not rule out SARS-
CoV2 infection. Hence in such cases a repeat sample should be sent. Lower respiratory tract samples
like Sputum, BAL, ET aspirate are appropriate samples especially in severe and progressive lung
disease.
3. Covid-19 Test conducted as per kits approved by ICMR / CE-IVD / USFDA.
4. Kindly consult referring Physician / Authorized hospitals for appropriate follow up.
5. This is a qualitative test. The Ct values do not provide a measure of viral load due to inherent variability
in sampling and kits. According to ICMR guidelines Ct values should not be used to gauge the severity
of the disease.
<https://www.icmr.gov.in/pdf/covid/techdoc/Advisory_on_correlation_of_COVID_severity_with_Ct_va l
ues.pdf>)
6. It is recommended that RTPCR test not be repeated in any individual who has tested positive once
either by RAT or RTPCR (ICMR guidelines).
7. No testing is required for COVID-19 recovered individuals at the time of hospital discharge in
accordance with the discharge policy of MoH&FW (https:// www.mohfw.gov.in/
<http://www.mohfw.gov.in/> pdf/ ReviseddischargePolicyforCOV/019.pdf).

Comments
Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more

* Not in NABL scope

Page 1 of 5
 L51 - ANNESHA

Name : Mr. ISHANK GUPTA Collected : 15/4/2022 5:00:00PM

Received : 15/4/2022 6:19:16PM
Male
Reported : 16/4/2022 10:33:29AM
Lab No. : 309575476 Age: 20 Years Gender:
A/c Status : P Ref By : Dr. .SELF Report Status : Final

severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory
Syndrome (SARS-CoV). Coronavirus disease (COVID-19) is a new strain that was discovered in 2019 and
has not been previously identified in humans. Common signs of infection include respiratory symptoms,
fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause
pneumonia, severe acute respiratory syndrome and kidney failure. Note: The results relate only to the
specimens tested and should be correlated with clinical findings. Interpretation guidance:
• Please ensure and maintain the confidentiality of the test report.
• Testing of referred clinical specimens were considered on the basis of request /referral received from/
through the State Surveillance Officer (SSO) of concerned State Integrated disease Surveillance
Programme(IDSP) / any other health facility affirming requirements of the case definition/s. • A single
negative test result, particularly if this is from an upper respiratory tract specimen, doesn’t exclude
infection.
• Repeat sampling and testing of lower respiratory specimen is strongly recommended for severe or
progressive disease. The repeat specimens can be considered after a gap of 2 to 4 days after the
collection of first specimen for additional testing if required.
• A positive alternate pathogen doesn’t necessarily rule out either, as little is yet known about the role of
coinfections. Testing of non-viral agent has not been undertaken.
• Please note that these results are not to be used for any thesis or presentations or for Publications in any
Journal without prior permission of Director General, ICMR.

|In case of COVID-19 Positive Report - | |Please contact for any information
to: |
| |
|*Integrated Help Line* - 1800-313244-122 |
| |
|*Direct Telemedicine Line*- 0891-2357-6001 |
| | |*Ambulance Service in Chennai for COVID-19 Patients* - 0891-4190-2229 | |
| |Source -Department of Health & Family Welfare,Government of Tamil Nadu) |
| |

* Not in NABL scope

Page 2 of 5
L51 - ANNESHA

Dr. Prajapati Khushboo Dr. Mohiruddin SK

Dr Mallika Ghosh
MD (Microbiology) MD, Microbiology
MD, Microbiology
Consultant Microbiologist Consultant Microbiologist
Incharge and Technical Lead –
Microbiology Serology Clinical

Pathology Molecular Diagnostics

KRL - Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

Name : Mr. ISHANK GUPTA Collected : 15/4/2022 5:00:00PM
Received : 15/4/2022 6:19:16PM
Gender: Male
Reported : 16/4/2022 10:33:29AM
Lab No. : 309575476 Age: 20 Years
A/c Status : P Ref By : Dr. .SELF Report Status : Final

* Not in NABL scope

Page 3 of 5
L51 - ANNESHA

* Not in NABL scope

4
Page 4 of